Skip to main navigation
Skip to search
Skip to main content
Sort by
Nursing and Health Professions
Primary Health Care
100%
Polypharmacy
95%
Economic and Social Development
95%
Primary Medical Care
94%
General Practitioner
93%
Qualitative Research
81%
Systematic Review
80%
Qualitative Study
79%
Nursing Home
74%
Community Pharmacist
62%
Adherence
55%
Pharmaceutical Care
43%
Potentially Inappropriate Medication
40%
Quality of Life
36%
General Practice
35%
Prevalence
35%
Medicines Management
33%
Health Practitioner
27%
Confidence Interval
27%
Health Care
27%
Scoping Review
26%
Decision-Making
25%
Deprescribing
24%
Patient Compliance
23%
Multiple Chronic Conditions
23%
Medication Therapy Management
21%
Medication Compliance
21%
Malignant Neoplasm
21%
Bronchiectasis
20%
Cross-Sectional Survey
20%
Diseases
20%
Care Home Resident
20%
Accident Prevention
19%
Adverse Drug Reaction
19%
Methicillin-Resistant Staphylococcus Aureus
18%
Clinical Trial
18%
Thematic Analysis
18%
Antiinfective Agent
17%
COVID-19
16%
Feasibility Study
16%
Education
16%
Infection Control
15%
Palliative Therapy
15%
Nurse
15%
Practice Guideline
15%
Health Care Personnel
14%
Urinary Tract Infection
12%
Antimicrobial Stewardship
12%
Likert Scale
12%
Odds Ratio
12%
Medicine and Dentistry
Primary Health Care
91%
Systematic Review
69%
Cohort Analysis
68%
Polypharmacy
57%
Potentially Inappropriate Medication
57%
Case-Control Study
44%
General Practitioner
39%
Colorectal Carcinoma
34%
Acetylsalicylic Acid
33%
Malignant Neoplasm
33%
Specific Mortality
33%
Health Outcomes
31%
General Medicine
31%
Breast Cancer
30%
Statin
30%
Randomized Controlled Trial
30%
Medicines Management
28%
Odds Ratio
28%
Hazard Ratio
26%
Quality of Life
25%
Low Drug Dose
22%
Behavioral Change
21%
Patient Compliance
20%
Bronchiectasis
20%
Oral
18%
Prevalence
16%
Likert Scale
15%
Education
15%
Health Care Cost
15%
Adverse Drug Reaction
14%
Medication Compliance
14%
Health Care Personnel
13%
Decision Making
13%
Cancer Mortality
13%
Multiple Chronic Conditions
12%
Middle Age
12%
Observational Study
11%
Nonsteroid Antiinflammatory Agent
11%
Prostate Cancer
11%
Digoxin
11%
Lung Cancer
11%
Pancreas Cancer
11%
Antimicrobial Agent
10%
Health Service
10%
Comorbidity
10%
Logistic Regression Analysis
10%
Indigenous Peoples
10%
Cross Sectional Study
10%
Hormone Substitution
9%
Cancer
9%
Pharmacology, Toxicology and Pharmaceutical Science
Polypharmacy
65%
Cohort Study
55%
Malignant Neoplasm
39%
Randomized Controlled Trial
34%
Prevalence
33%
Acetylsalicylic Acid
33%
Statin (Protein)
26%
Case-Control Study
25%
Pharmaceutical Care
24%
Breast Cancer
24%
Non-Steroidal Anti-Inflammatory Drug
23%
Community Pharmacy
23%
Colorectal Carcinoma
19%
Adverse Drug Reaction
19%
Morbidity
19%
Cholinergic Receptor Blocking Agent
15%
Cancer Survival
14%
Comorbidity
14%
Prostate Cancer
11%
Bronchiectasis
11%
Lung Cancer
11%
Antimicrobial Agent
11%
Proton Pump Inhibitor
10%
Base
10%
Antidepressant
10%
Cross-Sectional Study
9%
Multiple Chronic Conditions
9%
Adverse Event
9%
Pharmacy Practice
8%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
8%
Anxiolytic
8%
Observational Study
8%
Cross Sectional Study
7%
Pancreas Cancer
7%
Cluster Randomized Trial
7%
Visual Impairment
7%
Warfarin
7%
Angiotensin Receptor Antagonist
7%
Psychotropic Agent
7%
Head and Neck Cancer
7%
Anticoagulant Agent
7%
Antiinfective Agent
6%
Transdermal
6%
Cholinesterase Inhibitor
6%
Lisinopril
6%
Frailty
6%
Cancer Growth
5%
Cancer Registry
5%
Cardiovascular Disease
5%
Beers Criteria
5%